Although drug therapies such as testosterone, myostatin antibodies, and activin receptor antibodies might have potential effects on sarcopenia treatment,72 and recently a randomized controlled study reported that treatment with bimagrumab over 16 weeks increased muscle mass and strength in older adults with sarcopenia.73 The gene discussed is MSTN; the disease is sarcopenia.